SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-303137
Filing Date
2014-08-08
Accepted
2014-08-08 16:11:38
Documents
14
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d755155d10q.htm 10-Q 483608
2 EX-10.1 d755155dex101.htm EX-10.1 8984
3 EX-10.2 d755155dex102.htm EX-10.2 118058
4 EX-10.3 d755155dex103.htm EX-10.3 8840
5 EX-31.1 d755155dex311.htm EX-31.1 9125
6 EX-31.2 d755155dex312.htm EX-31.2 9104
7 EX-32.1 d755155dex321.htm EX-32.1 3976
8 EX-32.2 d755155dex322.htm EX-32.2 3955
  Complete submission text file 0001193125-14-303137.txt   2739611

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT cort-20140630.xml EX-101.INS 263656
10 XBRL TAXONOMY EXTENSION SCHEMA cort-20140630.xsd EX-101.SCH 23947
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20140630_cal.xml EX-101.CAL 38945
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20140630_def.xml EX-101.DEF 145452
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20140630_lab.xml EX-101.LAB 202454
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20140630_pre.xml EX-101.PRE 170538
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 141027602
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1